INTRATHECAL PUMPS MARKET ANALYSIS
Challenges in Intrathecal pumps market
Although to relive pain, intrathecal pumps are considered as effective tool, these pumps may have some risks and complications that must be addressed. In 2015, the U.S. Food and Drug Administration filed a court order against Medtronic ordering to stop production and distribution of its SynchroMed II intrathecal pain pumps due to defects in the surgically implanted pumps, which accused for over a dozen deaths. The devices either lost power or accidentally injected patients with high or low dosage of drug. Thus, product quality and safety is one of the aspects to safeguard against the medical complications.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
